Johnson & Johnson

The European Medicines Agency said Tuesday the Johnson & Johnson Covid-19 vaccine has possible links to rare blood clot incidents.

More than 195 million shots have been reported administered since Biden’s inauguration.

The U.S. is reporting 3 million daily shots given as President Biden’s deadline arrives for states to expand vaccine eligibility to all adults.

More than 129 million people ages 18 and older have received at least one vaccine shot, or 50.4% of the total adult population.

Health regulators have asked states to temporarily halt J&J’s single-dose shot after reports of six cases of rare brain blood clots in women.

New York City says anyone 50 years and older can get their dose of the COVID-19 vaccine at a city-run vaccination site without an appointment. NBC New York’s Myles Miller reports.

The rate of daily U.S. vaccine doses reported administered held above 3 million Thursday, and in many states, nearly 50% of residents have gotten inoculations.

It’s getting easier to book Pfizer or Moderna shots in New York City, apparently, despite the Johnson & Johnson pause. At the same time, the city’s mayor says vaccine hesitancy is declining.

There are already over 600 vaccine sites that are open New York City residents and another one will open Friday at the Queens Center mall. NBC New York’s Jen Maxfield reports.

Pfizer CEO Albert Bourla said people will “likely” need a third dose of a COVID-19 vaccine within 12 months of getting fully vaccinated.

The benchmark 10-year Treasury yield slid to a one-month low Thursday in a counterintuitive move that should be a positive for the stock market.

Gov. Andrew Cuomo says he will extend New York’s indoor restaurant service and catered events curfews by an hour each and welcome spectators back to horse and auto races next week, his latest reopening steps as statewide COVID hospitalizations fall below 4,000 for the first time since Dec. 1.

The nation’s top health officials are testifying before Congress Thursday as the U.S. enters a critical phase in its battle to emerge from the Covid pandemic.

Some people say they still prefer the single-dose vaccination afforded by Johnson & Johnson even as the CDC investigates the rare blood clot complications reported in a half-dozen women. News 4’s Gaby Acevedo reports.

The Johnson & Johnson vaccine pause gives medical authorities time to investigate the rare cases of blood clots and determine the cause. Dr. Jennifer Haythe, co-director of Columbia Women’s Heart Center, explains that this type of blood clot requires a different treatment than a typical clot, and symptoms to look out for.

The U.S. recommended states pause administering Johnson & Johnson vaccines after a half-dozen reports of rare complications involving blood clots in six women.

Tri-state health and elected officials sought to reassure New York, New Jersey and Connecticut residents about the safety and effectiveness of COVID-19 vaccines Wednesday as a CDC panel debated the Johnson & Johnson shot pause. NBC New York’s Ida Siegal reports.

U.S. health officials are weighing next steps as they investigate a handful of unusual blood clots in people who received Johnson & Johnson’s COVID-19 vaccine

Officials said that clarity regarding how long the Johnson & Johnson shot will last should come within the next few days — but until then, some of the city’s most vulnerable homebound residents won’t be able to get a vaccine. NBC New York’s Andrew Siff reports.

All six cases occurred in women ages 18 to 48, with symptoms developing six to 13 days after they received the shot.